BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Otsuka America Pharmaceutical, Inc. 

2440 Research Boulevard

Rockville  Maryland  20850  U.S.A.
Phone: 301-990-0030 Fax: 301-212-8620


View Clinical Trials from BioPharm Insight

Otsuka is a successful, global group of affiliated companies that discovers, develops and markets innovative products. In the U.S., Otsuka is hard at work investigating potential new treatments, with numerous compounds in various stages of development to treat disorders of the cardiovascular, gastrointestinal, respiratory, renal and central nervous systems, and to treat cancer and ophthalmic disorders. Our pharmaceutical products include ABILIFY® (aripiprazole) Tablets and intramuscular injection, IV BUSULFEX® (busulfan) Injection and PLETAL® (cilostazol) Tablets, although we no longer actively market PLETAL. We also have the BreathTek™ Urea Breath Test for H. pylori. We have numerous additional products in our pipeline that are currently under development. We are highly diversified, with pharmaceutical as well as consumer products such as Crystal Geyser Water, NatureMade® Vitamins, Ridge Wines, and diagnostic equipment.

Please visit our website at for more information.

 Key Statistics

Ownership: Subsidiary

Web Site: Otsuka America Pharmaceutical, Inc.


 Company News
Otsuka America Pharmaceutical, Inc. And Lundbeck Inc. (LUN.CO) To Present Data On Investigational Compound Brexpiprazole In Schizophrenia And Major Depressive Disorder At American Psychiatric Association Annual Meeting 5/13/2015 11:37:06 AM
H. Lundbeck A/S (LUN.CO) and Otsuka America Pharmaceutical, Inc. Release: Results Of Phase III Study Of Brexpiprazole In Adult Patients With Schizophrenia Published In American Journal Of Psychiatry 4/17/2015 7:40:06 AM
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: U.S. FDA Accepts For Review Supplemental New Drug Application For Deltoid Administration Of Abilify Maintena® (Aripiprazole) Extended-Release Injectable Suspension 12/15/2014 10:13:44 AM
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: Aripiprazole Once-Monthly Injectable Shows Superior Effectiveness To Paliperidone Palmitate Once-Monthly Injectable On Quality Of Life Scale In Patients With Schizophrenia 11/3/2014 10:57:38 AM
European Medicines Agency Accepts Otsuka America Pharmaceutical, Inc.'s Marketing Authorisation Application (MAA) For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD) 12/27/2013 7:38:51 AM
Bristol-Myers Squibb Company (BMY) and Otsuka America Pharmaceutical, Inc. Release: Four-Year Data From Phase 3 DASISION Trial Comparing Sprycel® (dasatinib) To Imatinib In First-Line Treatment Of Adults With Ph+ CP-CML Presented At Annual Meeting Of The American Society of Hematology 12/10/2013 6:56:26 AM
Almac Group Receives Appreciation Award From Otsuka America Pharmaceutical, Inc. 7/31/2013 9:54:30 AM
Almac Group Receives Appreciation Award From Otsuka America Pharmaceutical, Inc. 7/31/2013 7:11:20 AM
FDA Warns of Liver Injury Risk With Otsuka America Pharmaceutical, Inc.'s Tolvaptan 1/25/2013 8:40:49 AM
Otsuka America Pharmaceutical, Inc. Opens First Office in Canada 10/4/2010 12:31:57 PM